News

A vaccine candidate that can protect children from Meningococcal group B, which can lead to meningitis, has progressed to clinical development.

A new study sheds light on how viruses override their host cells’ carefully regulated DNA replicating system to make hundreds of new copies of themselves.

The antibody-based drug Beyfortus (nirsevimab-alip) has been approved by the FDA to prevent respiratory disease caused by respiratory syncytial virus (RSV) in babies and toddlers.

A team of researchers has now shown that PFAS can also reduce the activity of human immune cells and thus impair health.

Researchers have cracked how a particular type of immune cell develops in the body and protects against infection and disease.

A scorpionfish protein could prove a powerful tool for treating multidrug-resistant bacterial infections in people with cystic fibrosis.

A pair of new studies explains why babies get so many common respiratory infections and identifies a specialized cluster of immune cells found only in babies that help them cope with new pathogens.

Systemic autoimmune diseases are characterized by inflammation of multiple organs and can have devastating consequences for patients. There is a dire need for treatments against these diseases. RNase treatments seem promising in some clinical trials but not all.

Bioluminescent bacteria and the Hawaiian bobtail squid have formed a longstanding mutually beneficial relationship. How the bacteria coordinate their behavior to colonize the squid is detailed in new study.

DNA that folds into different shapes "like origami" has been used to direct the assembly of virus capsids, giving researchers control over virus protein shape, size and topology.